Mergers & Acquisitions
Chromos announces acquisition
Published in Vaccine Weekly, April 13th, 2005
Chromos will issue shares, warrants, and/or convertible notes to acquire all outstanding shares of Anosys.
Completion of the acquisition is subject to satisfactory due diligence, execution of definitive agreements, and approval by Anosys' shareholders and regulatory authorities.
"The acquisition of Anosys will provide a cash infusion, extend our operating runway, and expand our shareholder base," said Alistair Duncan, president and CEO of Chromos. "The transaction will also enhance our partnering opportunities, in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-04-13)
More Articles from Vaccine Weekly
- Immunization
Researchers plan strategy to defend neonates against encapsulated bacteria - Immunosupression
Everolimus and basiliximab allow CD4+ CD25+ cells to be effective - Leukemia
HLA-G expression is linked with an unfavorable outcome in lymphocytic leukemia - Transfusion
Heme-peptides will not trigger an adverse immune response in transfusion - Vaccine Development
Researchers analyze vaccine 17D as a vector for microbial T cell epitopes - Adenocarcinoma
Researchers study possibility of recombinant human prolactin for immunotherapy - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
